Medicaid prescription formulary restrictions and arthritis treatment costs

American Journal of Public Health

Volumn 98, Issue 7, 2008, Pages 1300-1305

  Johnson, Tricia J ^a   Stahl Moncada, Stephanie ^b  

^a RUSH UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CONSULTATION; DRUG FORMULARY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAID; OSTEOARTHRITIS; PRESCRIPTION; RHEUMATOID ARTHRITIS; UNITED STATES; AMBULATORY CARE; CROSS-SECTIONAL STUDY; DRUG COST; ECONOMICS; FACTUAL DATABASE; HEALTH CARE DELIVERY; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG COSTS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LINEAR MODELS; MEDICAID; MIDDLE AGED; OFFICE VISITS; OSTEOARTHRITIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 45549084074     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2007.118133     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. State prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation - United States, 2003. MMWR Morb Mortal Weekly Rep. 2005;55:477-480.
2. Thorpe KE, Florence CS, Joski P. Which medical conditions account for the rise in health care spending? Health Aff. 2004;W4:437-445.
3. Yelin E. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997. Arthritis Rheum. 2004;50:2317-2326.
4. US Food and Drug Administration. Patient Information Sheet: Celecoxib (Marketed as Celebrex) 2005. Available at: http://www.fda.gov/cder/drug/ infopage/celebrex/celebrex-ptsk.htm. Accessed January 31, 2008.
5. Cunningham PJ. Medicaid cost containment and access to prescription drugs. Health Aff. 2005;24:780-789.
6. Owens MK. State Medicaid program issues: preferred drug lists. Reston, VA: National Pharmaceutical Council; 2003.
7. Wilson J, Axelsen K, Tang S. Medicaid prescription drug access restrictions: exploring the effect on patient persistence with hypertension medications. Am J Manag Care. 2005;11:SP27-SP34.
8. Abdelgawad T, Egbuonu-Davis L. Preferred drug lists and Medicaid prescriptions. Pharmacoeconomics. 2006;24(suppl 3):55-63.
9. Ridley DB, Axelsen KJ. Impact of Medicaid preferred drug lists on therapeutic adherence. Pharmacoeconomics. 2006;24(suppl 3):65-78.
10. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298:61-69.
11. Fischer MA, Schneeweiss S, Avorn J, Solomon DH. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med. 2004;351:2187-2194.
12. Smalley WE, Griffin MR, Fought RL, Sullivan L, Ray WA. Effect of a prior-authorization requirement on the use of nonsteroidal anti-inflammatory drugs by Medicaid patients. N Engl J Med. 1995;332:1612-1617.
13. Momani AA, Madhaven SS, Nau DP. Impact of NSAIDs prior authorization policy on patients' quality of life. Ann Pharmacother. 2002;36:1681-1691.
14. Lichtenberg FR. The effect of access restrictions on the vintage of drugs used by Medicaid enrollees. Am J Manag Care. 2005;11:SP7-SP13.
15. Walser BL, Ross-Degnan D, Soumerai SB. Do open formularies increase access to clinically useful drugs? Health Aff. 1996;15:95-109.
16. US Dept of Health and Human Services. Annual update of the poverty guidelines. Fed Regist. 2003;68:6456-6458.
17. Kaiser Commission on Medicaid and the Uninsured. State Medicaid Fact Sheets: Arizona and United States. Available at: http://www.statehealthfacts. org/mfs.jsp?rgn=4&rgn=1&x=9&y=8. Accessed December 4, 2007.
18. Arizona Health Care Cost Containment System. AHCCCS Eligibility and Enrollment Reports - December 2003. Available at: http://www.ahcccs.state.az.us/ Statistics/AHCCCSpopulation/2003/Dec. Accessed December 20, 2006.
19. International Classification of Diseases, Ninth Revision, Clinical Modification. Hyattsville, MD: National Center for Health Statistics; 1980. DHHS publication PHS 80-1260.
20. Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY. Methods for analyzing health care utilization and costs. Annu Rev Public Health. 1999;20:125-144.